ALECTOR, INC.014442107US014442107206/17/2026Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER38872000FOR3887200FOR CYTOKINETICS, INCORPORATED23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5031750FOR503175FOR LYELL IMMUNOPHARMA, INC.55083R203US55083R203106/10/2026Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8003990FOR800399FOR RELAY THERAPEUTICS, INC.75943R102US75943R102306/09/2026To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER10000000FOR1000000FOR XENON PHARMACEUTICALS INC98420N105CA98420N105006/02/2026To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER1592810FOR159281FOR XENON PHARMACEUTICALS INC98420N105CA98420N105006/02/2026To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER15928101 YEAR159281FOR